CD5 and cancer: As such, CD5 may be a novel checkpoint therapy to regulate T cell activation and metabolism through altering Ca2+ mobilization, and could be used to affect neurological behavior, alter microbiome interactions, and treat cancer and autoinflammatory diseases.